Skip to main content
. 2005 Jul;79(13):8454–8469. doi: 10.1128/JVI.79.13.8454-8469.2005

TABLE 2.

Ninety percent inhibitory doses of entry inhibitors

Group and patient 90% inhibitory dose
CD4-IgG2 (μg/ml) IgG1b12 (μg/ml) RANTES (ng/ml) PRO 140 (μg/ml) AD101 (nM) T-20 (μg/ml) 2G12 (μg/ml) 2F5 (μg/ml) 4E10 (μg/ml)
Acute
    AK103 0.90 23.1 402 4.9 4.5 3.3 9.8 13.0 8.4
    AK104 0.90 24.8 397 1.1 1.3 4.2 >25 8.2 1.0
    AK105 0.70 13.7 313 0.24 1.9 0.46 >25 20.5 13.1
    AK112 0.86 13.5 48 1.0 1.9 0.92 1.7 3.0 1.5
    AK114 0.73 1.4 48 0.19 1.6 0.52 >25 6.5 1.3
    AK115 0.87 21.9 438 1.3 6.2 4.0 8.1 3.8 2.9
    AK116 87.0 >25 >500 >25 >25 9.5 23.7 11.5 13.9
    AK119 0.89 >25 195 1.3 1.7 2.2 7.5 3.5 1.7
    AK120 54.5 >25 420 2.3 10.6 4.8 1.5 4.6 2.5
    AK121 2.7 >25 359 1.0 0.89 5.4 0.9 4.2 1.5
    AK122 0.94 23.7 410 1.2 1.3 4.3 4.5 8.3 1.3
    AK125 0.87 20.1 225 1.1 2.1 4.8 >25 4.6 4.5
    002 2.3 24.0 47 2.2 1.0 0.87 >25 6.4 1.2
    003 0.91 >25 126 1.0 2.0 2.1 <0.2 3.8 1.7
    007 2.0 19.3 155 0.81 2.0 1.5 >25 5.7 2.1
    009 0.89 >25 393 9.4 2.0 4.8 20.0 15.0 9.1
    015 0.90 7.6 294 0.22 2.0 0.50 >25 3.5 7.2
    016 0.95 13.5 390 1.5 2.2 0.45 >25 2.9 1.7
    017 0.53 22.6 38 0.52 1.3 0.39 2.8 1.5 2.8
    018 0.94 20.7 340 0.57 2.0 4.3 >25 4.8 4.1
    019 1.0 >25 233 1.7 1.9 7.8 6.8 14.8 3.2
    020 4.5 >25 421 21.0 19.7 4.3 10.2 8.5 4.0
    021 3.7 >25 391 4.6 2.2 2.9 1.4 13.1 9.3
    022 0.90 11.6 205 1.1 1.4 0.89 >25 14.0 3.0
    023 4.2 >25 378 10.4 11.5 5.0 >25 >25 12.4
    025 4.5 2.4 48 1.7 1.8 2.8 <0.2 3.0 3.0
    026 0.61 >25 413 1.2 2.1 4.4 >25 18.8 6.3
Chronic
    102 5.4 >25 144 3.3 2.2 4.5 0.2 22.2 19.3
    105 1.0 0.008 46 0.11 2.2 0.58 0.4 8.4 7.6
    106 8.9 2.0 442 15.5 15.4 4.4 >25 14.0 6.6
    107 0.82 13.4 257 2.1 2.2 0.86 1.1 4.4 4.3
    109 0.95 22.4 345 8.1 9.9 0.87 >25 19.7 20.2
    111 0.76 13.6 257 0.34 1.1 4.0 18.4 13.5 4.5
    113 19.0 >25 465 8.6 7.5 2.6 18.7 23.7 >25
    114 0.49 9.9 422 1.3 10.6 4.7 18.0 >25 11.4
    115 3.8 >25 258 5.7 1.4 0.49 >25 >25 4.1
    116 92.0 >25 >500 24.4 >25 2.9 15.8 17.1 16.3
    117 0.93 >25 443 7.6 13.2 4.4 2.4 9.8 13.4
    118 0.89 >25 180 1.1 1.1 9.0 14.9 8.7 3.0
    119 7.5 >25 464 19.9 24.2 5.1 >25 15.5 9.9
    120 25.1 >25 368 6.0 2.2 0.56 13.4 15.2 14.9
    121 0.88 21.5 226 0.51 1.3 0.74 >25 23.0 23.0
    122 0.53 24.4 305 0.72 1.3 4.1 0.5 2.6 1.9
    123 0.88 24.2 222 0.89 10.9 2.2 >25 4.4 1.6
    125 0.90 11.3 234 0.22 1.3 0.38 >25 4.8 2.8
    126 15.9 >25 447 1.2 22.3 3.8 24.8 15.0 10.5
    127 0.90 >25 424 2.1 2.2 0.85 >25 22.0 16.0
    128 1.0 >25 215 0.25 1.6 9.2 >25 20.1 8.6
    130 0.73 23.0 241 0.22 2.0 2.7 >25 7.4 19.4
    S2201 4.7 >25 326 1.8 1.7 0.82 >25 >25 4.2
    S2202 22.3 13.2 236 11.6 2.3 9.2 14.2 4.4 4.2
    S2203 0.10 1.2 0.28 0.12 0.014 0.29 0.4 2.4 3.4
    S2204 0.92 11.3 405 1.5 2.0 4.9 <0.2 3.1 2.8
    S2206 41.8 24.4 >500 >25 >25 3.2 1.4 12.1 13.5
    S2208 0.89 12.7 250 0.24 1.8 4.6 1.2 >25 3.1
    AK111 0.63 24.9 110 0.93 0.13 0.73 >25 4.6 4.0
    AK117 0.94 >25 376 10.5 1.2 7.4 >25 14.1 8.0
    027 3.3 >25 447 1.7 11.0 4.1 >25 23.7 14.2